Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Six independent risk factors were identified: advanced age (OR = 4.054, 95%CI 2.281 to 7.237), disease duration (OR = 1.068, 95%CI 1.026 to 1.11), psoriatic arthritis (OR = 2.178, 95%CI 1.243 to 3.796), vitamin D deficiency (OR = 5.148, 95%CI 1.986 to 17.672), systemic corticosteroid use (OR = 3.501, 95%CI 1.756 to 6.826), male sex (OR = 0.399, 95%CI 0.229 to 0.686).
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cohort study.
Cohort study
Examines exposures and outcomes over time within a defined group.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
A retrospective cohort study was conducted including 639 psoriasis patients from January 2023 to October 2025.
Source: Abstract.
Patients were randomly divided into training (n = 447) and validation (n = 192) sets at a 7:3 ratio.
Source: Abstract.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Development and validation of a predictive nomogram for osteoporosis in patients with psoriasis
Cohort study · Frontiers in Medicine · 2026
Original publication title
Development and validation of a predictive nomogram for osteoporosis in patients with psoriasis
Copyright © 2026 Wang, Zhou, Jiang, Ma, Shen, Tang, Yi, Li and Wei.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Psoriasis is a chronic inflammatory disease associated with increased risk of osteoporosis. However, practical tools for identifying high-risk patients in clinical settings remain limited. This study aimed to develop and validate a nomogram for predicting osteoporosis in patients with psoriasis.
Source: BackgroundAbstract: What methods does the paper describe?
A retrospective cohort study was conducted including 639 psoriasis patients from January 2023 to October 2025. Patients were randomly divided into training (n = 447) and validation (n = 192) sets at a 7:3 ratio. Osteoporosis was defined as dual-energy X-ray absorptiometry (DXA) T-score ≤−2.5. Univariate analysis and multivariate logistic regression were performed to identify independent risk factors. A nomogram was constructed based on the final model and evaluated using C-index, calibration curves, and decision curve analysis (DCA).
Source: MethodsAbstract: Results
The overall prevalence of osteoporosis was 11.7% (75/639). Six independent risk factors were identified: advanced age (OR = 4.054, 95%CI 2.281 to 7.237), disease duration (OR = 1.068, 95%CI 1.026 to 1.11), psoriatic arthritis (OR = 2.178, 95%CI 1.243 to 3.796), vitamin D deficiency (OR = 5.148, 95%CI 1.986 to 17.672), systemic corticosteroid use (OR = 3.501, 95%CI 1.756 to 6.826), male sex (OR = 0.399, 95%CI 0.229 to 0.686). The nomogram demonstrated good discrimination with AUC of 0.824 in the training set and 0.771 in the validation set. Calibration curves showed excellent agreement between predicted and observed probabilities.
DCA confirmed the clinical utility of the model.
Source: ResultsAbstract: Conclusion
We developed and validated a practical nomogram incorporating psoriasis-specific and traditional risk factors for predicting osteoporosis risk. This tool may facilitate early identification of high-risk patients and guide clinical decision-making for DXA screening and preventive interventions.
Source: ConclusionAuthors’ abstract
Background
Psoriasis is a chronic inflammatory disease associated with increased risk of osteoporosis. However, practical tools for identifying high-risk patients in clinical settings remain limited. This study aimed to develop and validate a nomogram for predicting osteoporosis in patients with psoriasis.
Methods
A retrospective cohort study was conducted including 639 psoriasis patients from January 2023 to October 2025. Patients were randomly divided into training (n = 447) and validation (n = 192) sets at a 7:3 ratio. Osteoporosis was defined as dual-energy X-ray absorptiometry (DXA) T-score ≤−2.5. Univariate analysis and multivariate logistic regression were performed to identify independent risk factors. A nomogram was constructed based on the final model and evaluated using C-index, calibration curves, and decision curve analysis (DCA).
Results
The overall prevalence of osteoporosis was 11.7% (75/639). Six independent risk factors were identified: advanced age (OR = 4.054, 95%CI 2.281 to 7.237), disease duration (OR = 1.068, 95%CI 1.026 to 1.11), psoriatic arthritis (OR = 2.178, 95%CI 1.243 to 3.796), vitamin D deficiency (OR = 5.148, 95%CI 1.986 to 17.672), systemic corticosteroid use (OR = 3.501, 95%CI 1.756 to 6.826), male sex (OR = 0.399, 95%CI 0.229 to 0.686). The nomogram demonstrated good discrimination with AUC of 0.824 in the training set and 0.771 in the validation set. Calibration curves showed excellent agreement between predicted and observed probabilities.
DCA confirmed the clinical utility of the model.
Conclusion
We developed and validated a practical nomogram incorporating psoriasis-specific and traditional risk factors for predicting osteoporosis risk. This tool may facilitate early identification of high-risk patients and guide clinical decision-making for DXA screening and preventive interventions.
Publication and source details
Original title: Development and validation of a predictive nomogram for osteoporosis in patients with psoriasis
Zhilong Wang; Zhiyou Zhou; Ruichen Jiang; Haoning Ma; Yanzhu Shen; Xiangsheng Tang; Ping Yi; Yi Li; Zihan Wei
Frontiers in Medicine · 2026
* Correspondence: Ping Yi, CJFH_YPSpine@163.com; Yi Li, liyi_doc@163.com; Zihan Wei, weizihan@pku.edu.cnThese authors have contributed equally to this work and share first authorship
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T22:08:12.890974+00:00
DOI: 10.3389/fmed.2026.1826823 · PMC13395702